Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 5Pain 2Peripheral Nervous System Diseases 1Musculoskeletal Pain 1Drug-Related Side Effects and Adverse Reactions 1CIPN 1

Interventions

Zoledronic Acid 8Psychiatric Rehabilitation 6Analgesia 5Acupuncture Therapy 5Therapeutics 4Bupivacaine 4Surveys and Questionnaires 3Radiotherapy 3Ketamine 3Early Intervention, Educational 3Control Groups 3Calcium 3Yoga 2Pregabalin 2Music Therapy 2Melatonin 2Letrozole 2Interviews as Topic 2Fentanyl 2Fatty Acids, Omega-3 2Duloxetine Hydrochloride 2Calcium Gluconate 2Art Therapy 2strontium chloride 1pegfilgrastim 1ixabepilone 1exemestane 1esmolol 1cyclobenzaprine 1Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pain × Duloxetine Hydrochloride × Breast × Clear all
NCT01598298 2022-12-16

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

SWOG Cancer Research Network

Phase 3 Completed
299 enrolled 10 charts
Breast

Breast Neoplasms, Pain

NCT01912612 2020-08-06

Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain

University of Michigan Rogel Cancer Center

Phase 2 Completed
82 enrolled 26 charts
Breast

Breast Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡